Chronic myeloid leukemia (CML) is a type of myeloproliferative neoplasm characterized by the presence of BCR/ABL1 fusions, resulting from a genetic alteration known as t(9; 22)(q34; q11) [1,2]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.